A clinical measure of DNA methylation predicts outcome in de novo acute myeloid leukemia.
Luskin MR, Gimotty PA, Smith C, Loren AW, Figueroa ME, Harrison J, Sun Z, Tallman MS, Paietta EM, Litzow MR, Melnick AM, Levine RL, Fernandez HF, Luger SM, Carroll M, Master SR, Wertheim GB.
Luskin MR, et al. Among authors: wertheim gb.
JCI Insight. 2016 Jun 16;1(9):e87323. doi: 10.1172/jci.insight.87323.
JCI Insight. 2016.
PMID: 27446991
Free PMC article.